Andrew Scott's most recent trade in BioCardia Inc. was a trade of 8,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on July 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioCardia Inc | Andrew Scott Blank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2026 | 8,000 | 23,313 | - | - | Stock Option (right to buy) | |
| T Stamp Inc (Class A) | Andrew Scott Francis | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2026 | 64,187 | 86,701 | - | 0 | Class A Common Stock, par value $0.01 per share | |
| T Stamp Inc (Class A) | Andrew Scott Francis | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2026 | 64,187 | 50,842 | - | - | Restricted Stock Units | |
| T Stamp Inc (Class A) | Andrew Scott Francis | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2026 | 10,025 | 115,029 | - | - | Restricted Stock Units | |
| T Stamp Inc (Class A) | Andrew Scott Francis | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2026 | 10,025 | 24,017 | - | 0 | Class A Common Stock, par value $0.01 per share | |
| T Stamp Inc (Class A) | Andrew Scott Francis | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 06 Apr 2026 | 9,628 | 77,073 | - | 2.6 | 25,033 | Class A Common Stock, par value $0.01 per share |
| T Stamp Inc (Class A) | Andrew Scott Francis | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 06 Apr 2026 | 1,503 | 22,514 | - | 2.6 | 3,908 | Class A Common Stock, par value $0.01 per share |
| T Stamp Inc (Class A) | Andrew Scott Francis | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 50,842 | 125,054 | - | - | Restricted Stock Units | |
| BioCardia Inc | Andrew Scott Blank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2025 | 12,000 | 15,313 | - | - | Stock Option (right to buy) | |
| HCM II Acq Corp (Class A) | Andrew Scott Brenner | Former Director | Other type of transaction at price $ 0.00 per share. | 28 Oct 2025 | 25,000 | 25,000 | - | - | Common Stock, par value $0.0001 per share | |
| BioCardia Inc | Andrew Scott Blank | Director | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 19 Sep 2025 | 288,000 | 634,023 (9%) | 4% | 1.3 | 360,000 | Common Stock |
| BioCardia Inc | Andrew Scott Blank | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Sep 2025 | 288,000 | 602,522 | - | - | Warrant (right to buy) | |
| BioCardia Inc | Andrew Scott Blank | Director | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 30 Jun 2025 | 72,289 | 346,023 (5%) | 1% | 2.1 | 150,000 | Common Stock |
| BioCardia Inc | Andrew Scott Blank | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jun 2025 | 72,289 | 314,522 | - | - | Warrant (right to buy) | |
| BioCardia Inc | Andrew Scott Blank | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Apr 2025 | 131,233 | 242,233 | - | - | Warrant (right to buy) | |
| BioCardia Inc | Andrew Scott Blank | Director | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 23 Apr 2025 | 131,233 | 265,957 (3%) | 1% | 1.9 | 249,999 | Common Stock |
| T Stamp Inc (Class A) | Andrew Scott Francis | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 64,187 | 74,212 | - | - | Restricted Stock Units | |
| WPP PLC. (ADR) | Andrew Scott | Executive Director,Chief Operating Officer | 14 Mar 2025 | 107,214 | 983,754 (0%) | 0% | 0 | Ords 0.10p | ||
| WPP PLC. (ADR) | Andrew Scott | Executive Director,Chief Operating Officer | 14 Mar 2025 | 50,492 | 933,262 (0%) | 0% | 6.3 | 320,119 | Ords 0.10p | |
| WPP PLC. (ADR) | Andrew Scott | Executive Director,Chief Operating Officer | 10 Mar 2025 | 50,609 | 900,374 (0%) | 0% | 0 | Ords 0.10p | ||
| WPP PLC. (ADR) | Andrew Scott | Executive Director,Chief Operating Officer | 10 Mar 2025 | 23,834 | 876,540 (0%) | 0% | 6.4 | 152,538 | Ords 0.10p | |
| T Stamp Inc (Class A) | Andrew Scott Francis | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 8,933 | 10,025 | - | - | Restricted Stock Units | |
| T Stamp Inc (Class A) | Andrew Scott Francis | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 8,933 | 15,331 | - | 0 | Class A Common Stock, par value $0.01 per share | |
| T Stamp Inc (Class A) | Andrew Scott Francis | Director, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.26 per share. | 07 Mar 2025 | 1,339 | 13,992 | - | 2.3 | 3,026 | Class A Common Stock, par value $0.01 per share |
| T Stamp Inc (Class A) | Andrew Scott Francis | Director, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 10,025 | 18,958 | - | - | Restricted Stock Units | |
| BioCardia Inc | Andrew Scott Blank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2024 | 829 | 3,313 | - | - | Stock Option (right to buy) | |
| BioCardia Inc | Andrew Scott Blank | Director | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 03 Sep 2024 | 111,000 | 134,724 (1%) | 1% | 3 | 333,000 | Common Stock |
| BioCardia Inc | Andrew Scott Blank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 111,000 | 111,000 | - | - | Warrant (right to buy) | |
| WPP PLC. (ADR) | Andrew Scott | Executive Director,Chief Operating Officer | 11 Mar 2024 | 50,890 | 68,147 (0%) | 0% | 0 | Ords 0.10p | ||
| WPP PLC. (ADR) | Andrew Scott | Executive Director,Chief Operating Officer | 11 Mar 2024 | 23,967 | 44,180 (0%) | 0% | 7.0 | 168,248 | Ords 0.10p | |
| BioCardia Inc | Andrew Scott Blank | Director | Grant, award, or other acquisition of securities at price $ 2.34 per share. | 23 Jun 2023 | 64,212 | 211,404 (3%) | 0% | 2.3 | 149,999 | Common Stock |
| BioCardia Inc | Andrew Scott Blank | Director | Grant, award, or other acquisition of securities at price $ 1.68 per share. | 16 Dec 2022 | 148,809 | 291,659 (4%) | 2% | 1.7 | 249,999 | Common Stock |
| BioCardia Inc | Andrew Scott Blank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 12,434 | 24,868 | - | - | Stock Option (right to buy) |